MedTrace Logo

Serum Concentrations of Antidepressant Drugs in Pregnant Women - a Naturalistic Study

NCT04806230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2021-03-19

No results posted yet for this study

Summary

The study was a prospective naturalistic PK study of five frequently used antidepressant drugs in pregnant women; citalopram (CIT), escitalopram (ECIT), sertraline (SERT), mirtazapine (MIRT) and venlafaxine VEN) and their major metabolites (Table 1). After signing informed consent pregnant women with ongoing antidepressant treatment, regardless of indication, were recruited at nine antenatal care centers in mid- and small cities and villages in the Southeast Sweden between April 2011 and September 2013.

Conditions

  • Pharmacokinetics
  • Antidepressive Agents
  • Pregnancy

Interventions

DRUG

sertraline, mirtazapine, venlafaxine, citalopram, escitalopram

Naturalistic treatment

Sponsors & Collaborators

  • Linkoeping University

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-01
Primary Completion
2013-09-30
Completion
2013-09-30
FDA Drug
Yes

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04806230 on ClinicalTrials.gov